In rereading the trial design and exclusion criteria there doesn’t appear to be anything tying participation to the beginning of disease, but rather to baseline symptoms. If their symptoms meet the criteria and there are no exclusion issues, it seems like being 20+ days from when they were diagnosed wouldn’t/doesn’t matter. Perhaps that’s how they are getting in.